ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models
Snehal Nirgude(Children's Hospital of Philadelphia), Bibha Choudhary(Institute of Bioinformatics and Applied Biotechnology)
Cited by 39
Related Papers
A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells
|Scientific Reports|2016|79
Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines
|BMC Complementary and Alternative Medicine|2019|62